Alexandra Miranville

Alexandra Miranville is an accomplished professional in business development within the biotechnology and pharmaceutical sectors. Currently serving as the Director of Business Development at BioNTech SE since October 2023, Alexandra previously held significant leadership roles at Merck KGaA from 2012 to 2023, including Director of Global Business Development focusing on Neurology and Immunology. Alexandra's expertise includes leading deal structuring and negotiations, managing cross-functional teams, and mentoring junior staff. Earlier experience includes project management at sanofi-aventis, where responsibilities encompassed designing research proposals and negotiating R&D agreements, as well as conducting research as a PostDoc. Alexandra holds a PhD in Biology from Goethe University Frankfurt and has pursued advanced training in team coaching and executive coaching.